20225907

Source:http://linkedlifedata.com/resource/pubmed/id/20225907

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0016360, umls-concept:C0036525, umls-concept:C0087111, umls-concept:C0205390, umls-concept:C0439841, umls-concept:C1274040, umls-concept:C1522484, umls-concept:C1527249, umls-concept:C1547135, umls-concept:C1547139, umls-concept:C1561560, umls-concept:C1561561, umls-concept:C2603343, umls-concept:C2721771
pubmed:issue	4
pubmed:dateCreated	2010-3-15
pubmed:abstractText	Combined therapy with irinotecan/fluorouracil/levoleucovorin (calcium levofolinate) [IFL] has lost its position as the standard regimen for metastatic colorectal cancer because its toxicity and effectiveness have become controversial.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9504817
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Leucovorin
pubmed:status	MEDLINE
pubmed:issn	1173-2563
pubmed:author	pubmed-author:AsakaMasahiroM, pubmed-author:FuseNozomuN, pubmed-author:KatoTakashiT, pubmed-author:KomatsuYoshitoY, pubmed-author:KudoMineoM, pubmed-author:KuniedaYasuyukiY, pubmed-author:MiyagishimaTakutoT, pubmed-author:SakataYuY, pubmed-author:TateyamaMikiM, pubmed-author:WakahamaOsamuO, pubmed-author:WatanabeMasaoM, pubmed-author:YuukiSatoshiS
pubmed:issnType	Print
pubmed:volume	30
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	243-9
pubmed:meshHeading	pubmed-meshheading:20225907-Adolescent, pubmed-meshheading:20225907-Adult, pubmed-meshheading:20225907-Aged, pubmed-meshheading:20225907-Ambulatory Care, pubmed-meshheading:20225907-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:20225907-Camptothecin, pubmed-meshheading:20225907-Colorectal Neoplasms, pubmed-meshheading:20225907-Disease Progression, pubmed-meshheading:20225907-Dose-Response Relationship, Drug, pubmed-meshheading:20225907-Drug Administration Schedule, pubmed-meshheading:20225907-Female, pubmed-meshheading:20225907-Fluorouracil, pubmed-meshheading:20225907-Humans, pubmed-meshheading:20225907-Leucovorin, pubmed-meshheading:20225907-Male, pubmed-meshheading:20225907-Maximum Tolerated Dose, pubmed-meshheading:20225907-Middle Aged, pubmed-meshheading:20225907-Neoplasm Metastasis, pubmed-meshheading:20225907-Survival Rate, pubmed-meshheading:20225907-Treatment Outcome, pubmed-meshheading:20225907-Young Adult
pubmed:year	2010
pubmed:articleTitle	Modified-irinotecan/fluorouracil/levoleucovorin therapy as ambulatory treatment for metastatic colorectal cancer: results of phase I and II studies.
pubmed:affiliation	Department of Gastroenterology, Hokkaido University, Sapporo, Japan.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II, Clinical Trial, Phase I